324 related articles for article (PubMed ID: 30610359)
1. Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?
Marra G; Ploussard G; Futterer J; Valerio M;
World J Urol; 2019 Feb; 37(2):277-287. PubMed ID: 30610359
[TBL] [Abstract][Full Text] [Related]
2. Transperineal Magnetic Resonance Imaging-Targeted Biopsy May Perform Better Than Transrectal Route in the Detection of Clinically Significant Prostate Cancer: Systematic Review and Meta-analysis.
Tu X; Liu Z; Chang T; Qiu S; Xu H; Bao Y; Yang L; Wei Q
Clin Genitourin Cancer; 2019 Oct; 17(5):e860-e870. PubMed ID: 31281065
[TBL] [Abstract][Full Text] [Related]
3. Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy.
Freifeld Y; Xi Y; Passoni N; Woldu S; Hornberger B; Goldberg K; Bagrodia A; Raj G; Margulis V; Cadeddu JA; Lotan Y; Francis F; Pedrosa I; G Roehrborn C; Costa DN
Urol Oncol; 2019 Jan; 37(1):57-62. PubMed ID: 30446460
[TBL] [Abstract][Full Text] [Related]
4. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis.
Uleri A; Baboudjian M; Tedde A; Gallioli A; Long-Depaquit T; Palou J; Basile G; Gaya JM; Sanguedolce F; Lughezzani G; Rajwa P; Pradere B; Roupret M; Briganti A; Ploussard G; Breda A
Eur Urol Oncol; 2023 Dec; 6(6):621-628. PubMed ID: 37634971
[TBL] [Abstract][Full Text] [Related]
5. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
6. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer.
Winoker JS; Wajswol E; Falagario U; Maritini A; Moshier E; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR
Urology; 2020 Dec; 146():278-286. PubMed ID: 32956688
[TBL] [Abstract][Full Text] [Related]
7. Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy.
Mischinger J; Kaufmann S; Russo GI; Harland N; Rausch S; Amend B; Scharpf M; Loewe L; Todenhoefer T; Notohamiprodjo M; Nikolaou K; Stenzl A; Bedke J; Kruck S
BJU Int; 2018 May; 121(5):791-798. PubMed ID: 29211932
[TBL] [Abstract][Full Text] [Related]
8. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
[TBL] [Abstract][Full Text] [Related]
9. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract][Full Text] [Related]
10. Initial experience of magnetic resonance imaging/ultrasonography fusion transperineal biopsy: Biopsy techniques and results for 75 patients.
Tae JH; Shim JS; Jin HJ; Yoon SG; No TI; Kim JY; Kang SH; Cheon J; Kang SG
Investig Clin Urol; 2018 Nov; 59(6):363-370. PubMed ID: 30402568
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging/Ultrasound Fusion-guided Transperineal Versus Magnetic Resonance Imaging/Ultrasound Fusion-guided Transrectal Prostate Biopsy-A Systematic Review.
Rai BP; Mayerhofer C; Somani BK; Kallidonis P; Nagele U; Tokas T
Eur Urol Oncol; 2021 Dec; 4(6):904-913. PubMed ID: 33478936
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
[TBL] [Abstract][Full Text] [Related]
13. Initial series of magnetic resonance imaging (MRI)-fusion targeted prostate biopsy using the first transperineal targeted platform available in the USA.
Kosarek CD; Mahmoud AM; Eyzaguirre EJ; Shan Y; Walser EM; Horn GL; Williams SB
BJU Int; 2018 Nov; 122(5):909-912. PubMed ID: 29569311
[TBL] [Abstract][Full Text] [Related]
14. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
15. The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancer.
Fourcade A; Payrard C; Tissot V; Perrouin-Verbe MA; Demany N; Serey-Effeil S; Callerot P; Coquet JB; Doucet L; Deruelle C; Joulin V; Nonent M; Fournier G; Valeri A
Scand J Urol; 2018 Jun; 52(3):174-179. PubMed ID: 29463177
[TBL] [Abstract][Full Text] [Related]
16. Targeted Biopsy With Reduced Number of Cores: Optimal Sampling Scheme in Patients Undergoing Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Prostate Biopsy.
Shen WW; Cui LG; Ran WQ; Sun Y; Jiang J; Pei XL; Chen W
Ultrasound Med Biol; 2020 May; 46(5):1197-1207. PubMed ID: 32107089
[TBL] [Abstract][Full Text] [Related]
17. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
[TBL] [Abstract][Full Text] [Related]
18. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
[TBL] [Abstract][Full Text] [Related]
19. How to Biopsy: Transperineal Versus Transrectal, Saturation Versus Targeted, What's the Evidence?
Grummet J
Urol Clin North Am; 2017 Nov; 44(4):525-534. PubMed ID: 29107269
[TBL] [Abstract][Full Text] [Related]
20. Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis.
Wu Q; Tu X; Zhang C; Ye J; Lin T; Liu Z; Yang L; Qiu S; Bao Y; Wei Q
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):212-221. PubMed ID: 37783837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]